Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Guilherme Domingues Kolinger(University Medical Center Groningen), Ronald Boellaard(Amsterdam Neuroscience), Rudi Dierckx(University Medical Center Groningen), G. Krämer(Johannes Gutenberg University Mainz), Adrianus J. de Langen(The Netherlands Cancer Institute), Otto S. Hoekstra(Amsterdam Neuroscience), David Vállez García(Pasqual Maragall Foundation), Virginie Frings, Egbert F. Smit(Dutch Cancer Society)
Cited by 49
Related Papers
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
|New England Journal of Medicine|2020|879
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|782
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562